[1] Yun, J., Li, Y., Xu, C.T. and Pan, B.R. (2011) Epidemi ology and Rb1 gene of retinoblastoma. International Jour nal of Ophthalmology, 4, 103-109.
[2] Knudson Jr., A.G. (1971) Mutation and cancer: Statistical study of retinoblastoma. Proceedings of the National Aca demy of Sciences of the United States of America, 68, 820-823. doi:10.1073/pnas.68.4.820
[3] Broaddus, E., Topham, A. and Singh, A.D. (2009) In cidence of retinoblastoma in the USA: 1975-2004. British Journal of Ophthalmology, 93, 21-23. doi:10.1136/bjo.2008.138750
[4] Benedict, W.L. (1929) Homologous retinoblastoma in identical twins. Transactions of the American Ophthal mological Society, 27, 173-176.
[5] Canty, C.A. (2009) Retinoblastoma: An overview for advanced practice nurses. Journal of the American Aca demy of Nurse Practitioners, 21, 149-155. doi:10.1111/j.1745-7599.2008.00378.x
[6] Dimaras, H., Dimba, E.A. and Gallie, B.L. (2010) Chal lenging the global retinoblastoma survival disparity through a collaborative research effort. British Journal of Oph thalmology, 94, 1415-1416. doi:10.1136/bjo.2009.174136
[7] Lohmann, D. (2010) Retinoblastoma. Advances in Ex perimental Medicine and Biology, 685, 220-227. doi:10.1007/978-1-4419-6448-9_21
[8] Du, W. and Pogoriler, J. (2006) Retinoblastoma family genes. Oncogene, 25, 5190-5200. doi:10.1038/sj.onc.1209651
[9] Harbour, W. (2001) Retinoblastoma: Pathogenesis and diagnosis. In: Char, D.H., Ed., Tumours of the Eye and Ocular Adenexa, American Cancer Society, Atlas of Cli nical Oncology, BC Decker Inc., Hamilton, 253.
[10] Muhammad, M.H. (1987) A statistical analysis of 581 primary orbital tumours in Pakistan. Pakistan Journal of Ophthalmology, 3, 111-114.
[11] Nabie, R., Taheri, N., Fard, A.M. and Fouladi, R.F. (2012) Characteristics and clinical presentations of pediatric re tinoblastoma in North-Western Iran. International Jour nal of Ophthalmology, 5, 510-512.
[12] Lohmann, D.R., Brandt, B., Hopping, W., Passarge, E. and Horsthemke, B. (1996) The spectrum of RB1 germ line mutations in hereditary retinoblastoma. American Journal of Human Genetics, 58, 940-949.
[13] Arif, M. and Islam, Z. (2010) Retinoblastoma: Poste nucleation orbital recurrence. Canadian Journal of Oph thalmology, 45, 606-609. doi:10.3129/i10-059
[14] Bhurgri, Y., Bhurgri, H., Usman, A., Faridi, N., Malik, J., et al. (2003) Epidemiology of ocular malignancies in Ka rachi. Asian Pacific Journal of Cancer Prevention, 4, 352-357.
[15] Saiju, R., Thakur, J., Karmacharya, P.C. and Shah, D.N. (2006) Retinoblastoma in Nepal: A clinical profile of 30 cases. Nepal Medical College Journal, 8, 171-175.
[16] Zhao, J., Li, S., Shi, J. and Wang, N. (2011) Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China. British Journal of Ophthalmology, 95, 1372-1375. doi:10.1136/bjo.2010.191130
[17] Balasubramanya, R., Pushker, N., Bajaj, M.S., Ghose, S., Kashyap, S., et al. (2004) Atypical presentations of retin oblastoma. Journal of Pediatric Ophthalmology and Stra bismus, 41, 18-24.
[18] Kashyap, S., Meel, R., Pushker, N., Sen, S., Bakhshi, S., et al. (2012) Clinical predictors of high risk histopa thology in retinoblastoma. Pediatric Blood & Cancer, 58, 356-361. doi:10.1002/pbc.23239
[19] Gunalp, I., Gunduz, K. and Arslan, Y. (1996) Retin oblastoma in Turkey—Treatment and prognosis. Japan ese Journal of Ophthalmology, 40, 95-102.
[20] Abdu, L. and Malami, S. (2011) Clinicopathological pattern and management of retinoblastoma in Kano, Ni geria. Annals of African Medicine, 10, 214-219. doi:10.4103/1596-3519.84705
[21] Shah, P.K., Kalpana, N., Narendran, V. and Ramakrishnan, M. (2011) Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma. Indian Journal of Ophthalmology, 59, 49-51. doi:10.4103/0301-4738.73714
[22] Eagle Jr., R.C. (2009) High-risk features and tumor dif ferentiation in retinoblastoma: A retrospective histopa thologic study. Archives of Pathology & Laboratory Me dicine, 133, 1203-1209.
[23] Shields, C.L., Shields, J.A., Baez, K.A., Cater, J. and De Potter, P.V. (1993) Choroidal invasion of retinoblastoma: Metastatic potential and clinical risk factors. British Jour nal of Ophthalmology, 77, 544-548. doi:10.1136/bjo.77.9.544
[24] Essuman, V., Ntim-Amponsah, C.T., Akafo, S., Renner, L. and Edusei, L. (2010) Presentation of retinoblastoma at a paediatric eye clinic in ghana. Ghana Medical Journal, 44, 10-15.
[25] Chawla, B., Sharma, S., Sen, S., Azad, R., Bajaj, M.S., et al. (2012) Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retin oblastoma: A prospective study. Ophthalmology, 119, 850 856. doi:10.1016/j.ophtha.2011.09.037
[26] Mukhopadhyay, S., Ghosh, S., Chattopadhyay, D. and Dutta, S.K. (2006) An observational study on retinob lastoma cases attending a medical college in Calcutta. Journal of the Indian Medical Association, 104, 67-70.
[27] Shields, C.L., Shields, J.A., Baez, K., Cater, J.R. and De Potter, P. (1994) Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer, 73, 692-698. doi:10.1002/1097-0142(19940201)73:3<692::AID-CNCR2820730331>3.0.CO;2-8
[28] Yang, I.H., Kuo, H.K., Chen, Y.J., Lee, J.J. and Lin, S.A. (2008) Review of 20 years’ clinical experience with re tinoblastomas in southern Taiwan. Chang Gung Medical Journal, 31, 484-491.
[29] Yu, C.L., Tucker, M.A., Abramson, D.H., Furukawa, K., Seddon, J.M., et al. (2009) Cause-specific mortality in long-term survivors of retinoblastoma. Journal of the Na tional Cancer Institute, 101, 581-591. doi:10.1093/jnci/djp046